Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001020229-09-000005
Filing Date
2009-01-29
Accepted
2009-01-29 16:09:30
Documents
1
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 4499
  Complete submission text file 0001020229-09-000005.txt   6255
Mailing Address 12085 RESEARCH DRIVE ALACHUA FL 32615
Business Address 12085 RESEARCH DRIVE ALACHUA FL 32615 3864184018
ORAGENICS INC (Issuer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 390 PLANDOME RD. MANHASSET NY 11030
Business Address 516-627-5556
HAWES GEORGE T (Reporting) CIK: 0001300974 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-32188 | Film No.: 09554636